FDA happenings: FDA to review late thrombosis in drug-eluting stents; Agency grants HUD exemption to implantable artificial heart; Agency approves integrated IVUS-imaging technology
Around the industry: J&J sues BSC, Abbott over Guidant acquisition; HUD exemptions for PFO devices withdrawn; FoxHollow acquires Kerberos; and more
Proceedings of TCT 3, 15-16 (2006).
Fluent in Science 